Association between the TP53 and CYP2E1*5B gene polymorphisms and non-small cell lung cancer
, , , , , , oraz | 22 gru 2016
O artykule
Data publikacji: 22 gru 2016
Zakres stron: 311 - 316
Otrzymano: 01 kwi 2016
Przyjęty: 01 gru 2016
DOI: https://doi.org/10.1515/aiht-2016-67-2812
Słowa kluczowe
© Institute for Medical Research and Occupational Health
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
Ahmet Oguz Ada
Department of Toxicology, Faculty of Pharmacy, University of Ankara, 06100 Tandoğan, Ankara, Turkey
Serdar Bilgen
Department of Toxicology, Faculty of Pharmacy, University of Ankara, Ankara, Turkey
Volkan Karacaoglan
Department of Toxicology, Faculty of Pharmacy, University of Ankara, Ankara, Turkey
Celalettin Semih Kunak
Department of Toxicology, Faculty of Pharmacy, University of Ankara, Ankara, Turkey
Emre Soydas
Department of Toxicology, Faculty of Pharmacy, University of Ankara, Ankara, Turkey
Sibel Alpar
Ataturk Pulmonary Diseases and Thoracic Surgery Hospital, Ankara, Turkey
Meral Gulhan
Ataturk Pulmonary Diseases and Thoracic Surgery Hospital, Ankara, Turkey
Mumtaz Iscan
Department of Toxicology, Faculty of Pharmacy, University of Ankara, Ankara, Turkey